Health officials are preparing to issue new guidance regarding the use of a widely available over-the-counter pain reliever, commonly used around the world. The advisory is aimed at pregnant women, emphasizing caution when considering the medication for pain relief.
According to reports, the warning will advise pregnant women to only use the medication if they have a fever, rather than for general pain management. The move is part of ongoing efforts to ensure maternal and fetal health, following recent studies indicating potential risks associated with the drug during pregnancy.
The medication in question is among the most frequently purchased over-the-counter drugs globally, making the guidance particularly significant. Health authorities are expected to update healthcare providers and the public through official channels to promote safer use of the drug among expectant mothers.
Officials have not issued detailed safety data publicly but emphasized the importance of consulting healthcare professionals before using any medication during pregnancy. The new recommendations reflect a cautious approach aimed at minimizing potential adverse effects while balancing the medication’s benefits for conditions like fever.